{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:04:06Z","timestamp":1788879846103,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ejim.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T10:34:58Z","timestamp":1462098898000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Pregnancy in women with systemic lupus erythematosus (SLE)"],"prefix":"10.1016","volume":"32","author":[{"given":"Gabriella","family":"Moroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0005","doi-asserted-by":"crossref","first-page":"127.e1","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ejim.2016.04.005_bb0010","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.ejim.2016.04.005_bb0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ard.60.6.599","article-title":"Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre","volume":"60","author":"Huong","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.ejim.2016.04.005_bb0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/01443610400007836","article-title":"Pregnancy outcome in women with pre-existing lupus nephritis","volume":"24","author":"Soubassi","year":"2004","journal-title":"J. Obstet. Gynaecol."},{"issue":"9","key":"10.1016\/j.ejim.2016.04.005_bb0025","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.100997","article-title":"Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis","volume":"38","author":"Bramham","year":"2011","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3899\/jrheum.090872","article-title":"The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications","volume":"37","author":"Gladman","year":"2010","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10067-012-1941-4","article-title":"Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy","volume":"31","author":"Saavedra","year":"2012","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1586\/eci.12.36","article-title":"Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management","volume":"8","author":"Stojan","year":"2012","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/41.6.643","article-title":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies","volume":"41","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jcma.2014.11.008","article-title":"Pregnancy outcome of systemic lupus erythematosus in relation to lupus activity before and during pregnancy","volume":"78","author":"Yang","year":"2015","journal-title":"J. Chin. Med. Assoc."},{"issue":"7","key":"10.1016\/j.ejim.2016.04.005_bb0055","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0961203315572715","article-title":"Pregnancy and patients with preexisting lupus nephritis: 15years of experience at a single center in Korea","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/BOR.0b013e328363ebf7","article-title":"Pathogenesis of pregnancy complications in systemic lupus erythematosus","volume":"25","author":"Ostensen","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11906-013-0329-4","article-title":"Preeclampsia and the future risk of hypertension: the pregnant evidence","volume":"15","author":"Garovic","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"10.1016\/j.ejim.2016.04.005_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2013.04.012","article-title":"Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy","volume":"229","author":"Weissgerber","year":"2013","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.ejim.2016.04.005_bb0075","first-page":"1709","article-title":"Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period","volume":"32","author":"Clark","year":"2005","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.20864","article-title":"The impact of increased lupus activity on obstetric outcomes","volume":"52","author":"Clowse","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/ajkd.2002.35678","article-title":"Pregnancy in lupus nephritis","volume":"40","author":"Moroni","year":"2002","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/0961203308097575","article-title":"Maternal and foetal outcomes in pregnant patients with active lupus nephritis","volume":"18","author":"Wagner","year":"2009","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.ejim.2016.04.005_bb0100","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3899\/jrheum.100746","article-title":"The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus","volume":"38","author":"Clowse","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0015-0282(16)58565-3","article-title":"Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies","volume":"66","author":"Yetman","year":"1996","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejim.2016.04.005_bb0110","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/oxfordjournals.humrep.a135907","article-title":"High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies","volume":"10","author":"Rai","year":"1995","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.ejim.2016.04.005_bb0115","first-page":"59","article-title":"Fetal cardiac function during the first trimester of pregnancy","volume":"5","author":"Valenti","year":"2011","journal-title":"J. Prenat. Med."},{"issue":"12","key":"10.1016\/j.ejim.2016.04.005_bb0120","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1600-0412.2011.01236.x","article-title":"High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome","volume":"90","author":"Simchen","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6\u20137","key":"10.1016\/j.ejim.2016.04.005_bb0125","doi-asserted-by":"crossref","first-page":"A520","DOI":"10.1016\/j.autrev.2011.12.002","article-title":"Fetal outcome in autoimmune diseases","volume":"11","author":"Carvalheiras","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.ejim.2016.04.005_bb0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0961203312444172","article-title":"Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome","volume":"21","author":"De Carolis","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.ejim.2016.04.005_bb0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1191\/0961203302lu173oa","article-title":"Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA\/Ro-SSB\/La antibodies","volume":"11","author":"Askanase","year":"2002","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.ejim.2016.04.005_bb0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/OGX.0b013e318239e1ee","article-title":"Lupus and pregnancy","volume":"66","author":"Baer","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.ejim.2016.04.005_bb0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3899\/jrheum.090872","article-title":"The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications","volume":"37","author":"Gladman","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0150","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s11255-015-1032-y","article-title":"Clinical outcomes and predictors of fetal and maternal consequences of pregnancy in lupus nephritis","volume":"47","author":"Lv","year":"2015","journal-title":"Int. Urol. Nephrol."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0897.2005.00263.x","article-title":"Class III\u2013IV proliferative lupus nephritis and pregnancy: a study of 42 cases","volume":"53","author":"Carmona","year":"2005","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.ejim.2016.04.005_bb0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-014-8572-6","article-title":"Predictors of maternal and fetal complications in SLE patients: a prospective study","volume":"60","author":"Borella","year":"2014","journal-title":"Immunol. Res."},{"issue":"8","key":"10.1016\/j.ejim.2016.04.005_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104375","article-title":"Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares\u2014a case control study","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0170","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0002-9343(84)90538-2","article-title":"Lupus pregnancy. Case\u2013control prospective study demonstrating absence of lupus exacerbation during or after pregnancy","volume":"77","author":"Lockshin","year":"1984","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.ejim.2016.04.005_bb0175","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/art.1780361011","article-title":"Lupus and pregnancy studies","volume":"36","author":"Urowitz","year":"1993","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.ejim.2016.04.005_bb0180","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/art.1780341210","article-title":"Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience","volume":"34","author":"Petri","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/rheumatology\/35.2.133","article-title":"Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies","volume":"35","author":"Ruiz-Irastorza","year":"1996","journal-title":"Br. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.ejim.2016.04.005_bb0190","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1191\/096120398678920776","article-title":"Flares in lupus nephritis: incidence, impact on renal survival and management","volume":"7","author":"Ponticelli","year":"1998","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.ejim.2016.04.005_bb0195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.autrev.2014.02.007","article-title":"Rapidly progressive crescentic glomerulonephritis: early treatment is a must","volume":"13","author":"Moroni","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.ejim.2016.04.005_bb0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0167-5699(93)90235-D","article-title":"Bidirectional cytokine interactions in the maternal\u2013fetal relationship: is successful pregnancy a Th2 phenomenon?","volume":"14","author":"Wegmann","year":"1993","journal-title":"Immunol. Today"},{"issue":"6","key":"10.1016\/j.ejim.2016.04.005_bb0205","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0210","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.ejim.2016.04.005_bb0215","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.0903275","article-title":"Tim-3\/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells","volume":"185","author":"Dardalhon","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ejim.2016.04.005_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092371","article-title":"Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3\/galectin-9 interaction and its possible role during pregnancy","volume":"9","author":"Meggyes","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejim.2016.04.005_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071811","article-title":"Involvement of galectin-9\/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia","volume":"8","author":"Miko","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ejim.2016.04.005_bb0230","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/eji.200425929","article-title":"Changes in systemic type 1 and type 2 immunity in normal pregnancy and preeclampsia may be mediated by natural killer cells","volume":"35","author":"Borzychowski","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1034\/j.1600-0897.2002.1o041.x","article-title":"Normal pregnancy is associated with peripheral leukocyte activation","volume":"47","author":"Luppi","year":"2002","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.ejim.2016.04.005_bb0240","doi-asserted-by":"crossref","first-page":"84.e1","DOI":"10.1016\/j.ajog.2007.12.013","article-title":"Plasma of pregnant and preeclamptic women activates monocytes in vitro","volume":"199","author":"Faas","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2\u20133","key":"10.1016\/j.ejim.2016.04.005_bb0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12026-014-8577-1","article-title":"Risk factors of systemic lupus erythematosus flares during pregnancy","volume":"60","author":"Jara","year":"2014","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.ejim.2016.04.005_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/glycob\/cws120","article-title":"Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"23","author":"Sarter","year":"2013","journal-title":"Glycobiology"},{"issue":"7","key":"10.1016\/j.ejim.2016.04.005_bb0255","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0961203312443422","article-title":"Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome","volume":"21","author":"Janko","year":"2012","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.ejim.2016.04.005_bb0260","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0265","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Euro-Phospholipid Project Group Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0270","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0961203309360543","article-title":"Antiphospholipid syndrome: critical analysis of the diagnostic path","volume":"19","author":"Pengo","year":"2010","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.ejim.2016.04.005_bb0275","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.autrev.2014.05.001","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends","volume":"13","author":"Bertolaccini","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.ejim.2016.04.005_bb0280","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case\u2013control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","article-title":"The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women","volume":"64","author":"Le Thi","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.ejim.2016.04.005_bb0290","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2014.02.003","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome","volume":"13","author":"de Jesus","year":"2014","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.ejim.2016.04.005_bb0295","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fimmu.2015.00205","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome during pregnancy: diagnostic concepts","volume":"6","author":"Levy","year":"2015","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.ejim.2016.04.005_bb0300","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrrheum.2012.133","article-title":"Management of pregnancy in systemic lupus erythematosus","volume":"8","author":"Lateef","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0305","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/1744666X.2015.1033404","article-title":"Immunosuppression in pregnant women with systemic lupus erythematosus","volume":"11","author":"Ponticelli","year":"2015","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"9198","key":"10.1016\/j.ejim.2016.04.005_bb0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"von Dadelszen","year":"2000","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ejim.2016.04.005_bb0315","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejim.2016.04.005_bb0320","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/bdra.23027","article-title":"Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence","volume":"94","author":"Polifka","year":"2012","journal-title":"Birth Defects Res."},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0325","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ndt\/gfn651","article-title":"Lupus nephritis and pregnancy in the 21st century","volume":"24","author":"Day","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0330","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/j.1523-1755.2000.00399.x","article-title":"Lupus nephritis and the anti-phospholipid antibody syndrome in pregnancy","volume":"58","author":"Singh","year":"2000","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ejim.2016.04.005_bb0335","first-page":"408","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0340","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1160\/TH14-03-0191","article-title":"Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study","volume":"112","author":"Ruffatti","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejim.2016.04.005_bb0345","doi-asserted-by":"crossref","DOI":"10.1177\/0961203315578765","article-title":"Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review","author":"Amengual","year":"2015","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0350","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ejim.2016.04.005_bb0355","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1517\/14740338.2014.951326","article-title":"Safety considerations when prescribing immunosuppression medication to pregnant women","volume":"13","author":"Gerosa","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejim.2016.04.005_bb0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"\u00d8stensen","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.ejim.2016.04.005_bb0365","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0370","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MJT.0b013e3182491e02","article-title":"Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring","volume":"21","author":"Bay Bj\u00f8rn","year":"2014","journal-title":"Am. J. Ther."},{"issue":"3","key":"10.1016\/j.ejim.2016.04.005_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajog.2011.07.042","article-title":"Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane systematic review","volume":"206","author":"McKinlay","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0380","series-title":"Dubois\u2019 Lupus Erythematosus and Related Syndromes 8th ed.","first-page":"455","article-title":"Pregnancy in women with SLE","author":"Clowse","year":"2013"},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0385","first-page":"161","article-title":"The risk of pregnancy in patients with lupus nephritis","volume":"16","author":"Moroni","year":"2003","journal-title":"J. Nephrol."},{"issue":"8","key":"10.1016\/j.ejim.2016.04.005_bb0390","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1191\/0961203305lu2169oa","article-title":"Cyclophosphamide for lupus during pregnancy","volume":"14","author":"Clowse","year":"2005","journal-title":"Lupus"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2016.04.005_bb0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00404-011-1859-0","article-title":"Successful pregnancy after cyclophosphamide therapy for lupus nephritis","volume":"283","author":"Lannes","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejim.2016.04.005_bb0400","first-page":"395","article-title":"Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tisuue diseases","volume":"59","author":"Palmer","year":"1986","journal-title":"Q. J. Med."},{"issue":"10","key":"10.1016\/j.ejim.2016.04.005_bb0405","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/bdra.20399","article-title":"Pregnancy outcome of women exposed to azathioprine during pregnancy","volume":"79","author":"Goldstein","year":"2007","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0410","article-title":"Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation","volume":"121\u201330","author":"Armenti","year":"2002","journal-title":"Clin. Transpl."},{"issue":"3","key":"10.1016\/j.ejim.2016.04.005_bb0415","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158A","author":"Hoeltzenbein","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"issue":"6","key":"10.1016\/j.ejim.2016.04.005_bb0420","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ajmg.a.32685","article-title":"Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature","volume":"149A","author":"Anderka","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"issue":"12","key":"10.1016\/j.ejim.2016.04.005_bb0425","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acr.22364","article-title":"Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes","volume":"66","author":"Al Maimouni","year":"2014","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"2","key":"10.1016\/j.ejim.2016.04.005_bb0430","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/ctr.12494","article-title":"The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation","volume":"29","author":"Kim","year":"2015","journal-title":"Clin. Transpl."},{"issue":"8","key":"10.1016\/j.ejim.2016.04.005_bb0435","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2016.04.005_bb0440","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMra050431","article-title":"Pregnancies in recipients of solid organs","volume":"354","author":"McKay","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejim.2016.04.005_bb0445","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar1977","article-title":"Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data","volume":"8","author":"Chambers","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.ejim.2016.04.005_bb0450","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ackd.2013.01.011","article-title":"Pregnancy in renal transplant recipients","volume":"20","author":"Hou","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"4","key":"10.1016\/j.ejim.2016.04.005_bb0455","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.06400612","article-title":"Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.ejim.2016.04.005_bb0460","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/s10165-010-0340-4","article-title":"Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus","volume":"21","author":"Alsuwaida","year":"2011","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.ejim.2016.04.005_bb0465","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/0961203314540353","article-title":"Tacrolimus is an effective treatment for lupus nephritis in pregnancy","volume":"23","author":"Webster","year":"2014","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.ejim.2016.04.005_bb0470","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.preghy.2014.10.225","article-title":"[219-POS]: Tacrolimus as the first choice of immunosuppressive therapy in kidney transplantation pregnant did not reduce significantly maternal and perinatal risks. A preliminary analysis","volume":"5","author":"Sass","year":"2015","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.ejim.2016.04.005_bb0475","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1096-9926(200102)63:2<106::AID-TERA1017>3.0.CO;2-R","article-title":"Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child","volume":"63","author":"Brent","year":"2001","journal-title":"Teratology"},{"issue":"7","key":"10.1016\/j.ejim.2016.04.005_bb0480","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/art.34419","article-title":"Organization of Teratology Information Specialists Collaborative Research Group. Pregnancy outcome in women exposed to leflunomide before or during pregnancy","volume":"64","author":"Cassina","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.ejim.2016.04.005_bb0485","first-page":"1723","article-title":"Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations","volume":"155A","author":"Ramasethu","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"issue":"5","key":"10.1016\/j.ejim.2016.04.005_bb0490","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10067-012-2156-4","article-title":"Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases","volume":"32","author":"Ojeda-Uribe","year":"2013","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"10.1016\/j.ejim.2016.04.005_bb0495","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s12098-013-1336-9","article-title":"B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen","volume":"81","author":"Mandal","year":"2014","journal-title":"Indian J. Pediatr."},{"issue":"8","key":"10.1016\/j.ejim.2016.04.005_bb0500","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/rheumatology\/ket409","article-title":"Biologic therapies and pregnancy: the story so far","volume":"53","author":"Hyrich","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2016.04.005_bb0505","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1097\/01.AOG.0000447366.55234.da","article-title":"Belimumab pregnancy registry: prospective cohort study of pregnancy outcomes","volume":"123","author":"Landy","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0510","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","article-title":"Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study","volume":"39","author":"Diav-Citrin","year":"2013","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.ejim.2016.04.005_bb0515","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.ejim.2016.04.005_bb0520","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.ejim.2016.04.005_bb0525","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516300747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516300747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T02:36:02Z","timestamp":1567823762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516300747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":105,"alternative-id":["S0953620516300747"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.04.005","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy in women with systemic lupus erythematosus (SLE)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}